NCT00588913 2013-07-10Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesNational Cancer Institute (NCI)Phase 1/2 Completed20 enrolled